These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 7560802)
41. [Macular lesions due to synthetic antimalarials]. Hache JC; Turut P; Dufour D Bull Soc Ophtalmol Fr; 1970 Dec; 70(12):1254-60. PubMed ID: 5526400 [No Abstract] [Full Text] [Related]
42. Chloroquine-induced retinal toxicity. Whitelaw D; Jessop S S Afr Med J; 2005 Feb; 95(2):72. PubMed ID: 15751191 [No Abstract] [Full Text] [Related]
43. Electrophysiological methods of examination during prolonged administration of synthetic antimalarial drugs. Svĕrák J; Peregrin J; Salavic M; Pastrnáková I Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1976; 19(3-4):427-34. PubMed ID: 1072532 [No Abstract] [Full Text] [Related]
44. [Spectral domain OCT in the early diagnosis of antimalarial maculopathy: A case report]. Zayani M; Ammari W; Najjar S; Bannour R; Karsou B; Lahmar N; Messaoud R; Khairallah M J Fr Ophtalmol; 2017 Mar; 40(3):e105-e107. PubMed ID: 28318710 [No Abstract] [Full Text] [Related]
45. [Ocular involvement in chloroquine therapy]. Godel V; Nemet P; Stein R Harefuah; 1972 Jul; 83(2):60-3. PubMed ID: 5068910 [No Abstract] [Full Text] [Related]
46. Eye damage from chloroquine as an antimalarial: misuse makes safe medicines unsafe. Waddell KM Trop Doct; 1997 Jan; 27(1):10-2. PubMed ID: 9030011 [No Abstract] [Full Text] [Related]
47. Optical coherence tomography in a patient with chloroquine-induced maculopathy. Ramchandani S; Ramchandani S Indian J Ophthalmol; 2009; 57(4):327-8. PubMed ID: 19574713 [No Abstract] [Full Text] [Related]
48. Chloroquine-induced retinal toxicity. Rivett K S Afr Med J; 2004 Jan; 94(1):41. PubMed ID: 14971230 [No Abstract] [Full Text] [Related]
49. [Maculopathy in a lupus patient after taking antimalarial drugs]. Abdelkhalek R; Hanafi Y Pan Afr Med J; 2014; 18():146. PubMed ID: 25419284 [No Abstract] [Full Text] [Related]
54. [Value of retinal electrophysiology during treatments by synthetic antimalarial drugs (author's transl)]. Perdriel G Med Trop (Mars); 1981; 41(5):493-6. PubMed ID: 7321839 [No Abstract] [Full Text] [Related]
55. [Eye toxicity of antimalarial agents]. Graña Gil J; Cabana Vázquez M; Vázquez González A; Sánchez Meizoso MO An Med Interna; 2002 Apr; 19(4):189-91. PubMed ID: 12090061 [TBL] [Abstract][Full Text] [Related]
56. [Maculopathy in case of the pit of the disc]. Kolár P Cesk Slov Oftalmol; 2005 Sep; 61(5):330-6. PubMed ID: 16206943 [TBL] [Abstract][Full Text] [Related]
57. Third-degree atrioventricular block in a patient under chloroquine therapy. Guedira N; Hajjaj-Hassouni N; Srairi JE; el Hassani S; Fellat R; Benomar M Rev Rhum Engl Ed; 1998 Jan; 65(1):58-62. PubMed ID: 9523387 [TBL] [Abstract][Full Text] [Related]
58. [Drugs and the eye]. Guerzider V; Bron A Rev Prat; 2000 Feb; 50(4):415-8. PubMed ID: 10748675 [No Abstract] [Full Text] [Related]
59. Current concepts in monitoring patients on antimalarials. Easterbrook M Aust N Z J Ophthalmol; 1998 May; 26(2):101-3. PubMed ID: 9630287 [No Abstract] [Full Text] [Related]